A male case of Sjögren’s syndrome presenting with generalized lymphadenopathy and swelling of both lacrimal and salivary glands which responded remarkably well to an administration of corticosteroids

Japanese Journal of Clinical Immunology

Volumn 23, Issue 1, 2000, Pages 22-29

  Yamamoto, Motohisa ^a   Takahashi, Hiroki ^a   Mizukoshi, Tsunenori ^a   Murakami, Rieko ^a   Tokuno, Tetsuya ^a   Makiguchi, Yusuke ^a   Imai, Kohzoh ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Corticosteroid; Hypergammagl obul inemia; Hypocomplementemia; Mikulicz s disease; Sj gren s syndrome

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTINUCLEAR ANTIBODY; PREDNISOLONE; SS A ANTIBODIES; SS B ANTIBODIES; SS-A ANTIBODIES; SS-B ANTIBODIES;

AGED; ARTICLE; BLOOD; CASE REPORT; HUMAN; IMMUNOLOGY; LACRIMAL APPARATUS; LYMPHATIC SYSTEM DISEASE; MALE; PATHOLOGY; SALIVARY GLAND; SJOEGREN SYNDROME;

AGED; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, ANTINUCLEAR; HUMANS; LACRIMAL APPARATUS; LYMPHATIC DISEASES; MALE; PREDNISOLONE; SALIVARY GLANDS; SJOGREN'S SYNDROME;

EID: 0034137864     PISSN: 09114300     EISSN: 13497413     Source Type: Journal    
DOI: 10.2177/jsci.23.22     Document Type: Article

References (9)

1. Scott, J.: Qualitative and quantitative observation on the histology of human labial salivary glands obtained post mortem. Jour. Biol. Buccale., 8: 187–200, 1980.
2. Scott, J.: Qualitative and quantitative observation on the histology of human labial salivary glands obtained post mortem. Jour. Biol. Buccale., 19: 1–14, 1996.
3. Haneji, N., Nakano, T., Takio, K. et al: Identification of α-fodrin as a candidate autoantigen in primary Sjögren syndrome. Science, 276: 604–607, 1997.
4. Scott, J.: Qualitative and quantitative observation on the histology of human labial salivary glands obtained post mortem. Jour. Biol. Buccale., 53: 2367–2370, 1995.
5. Alexander, E.L., Amett, F.C., Provost, T.T. et al: Sjögren’s syndrome-association of anti -Ro (SS-A) antibodies with vasculitis, hematologic abnormalities, and serologic hyperreactivity. Ann. Intern. Med., 98: 155–159, 1983.
6. Fox, P.C., Datiles, M., Atkinson, A.A. et al: Prednisone and piroxicam for treatment of primary Sjögren’s syndrome. Clin. Exp. Rheum., 11: 149–156, 1993.
7. Fox, P.C., Datiles, M., Atkinson, A.A. et al: Prednisone and piroxicam for treatment of primary Sjögren’s syndrome. IgG 4 Sjögren 33: 249–254, 1993.
8. Fox, P.C., Datiles, M., Atkinson, A.A. et al: Prednisone and piroxicam for treatment of primary Sjögren’s syndrome. IgG 4 Sjögren 329: 185–196, 1995.
9. P.C., Fox, M., Datiles, A.A., Atkinson, et al., Prednisone and piroxicam for treatment of primary Sjögren’s syndrome, Sjögren, (1997), 128, 157-158